Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study.

Zykova SN, Storhaug HM, Toft I, Chadban SJ, Jenssen TG, White SL.

Nutr J. 2015 May 14;14(1):49. [Epub ahead of print]

2.

The Cost to Government and Society of Chronic Kidney Disease Stage 1-5, a National Cohort Study.

Wyld ML, Lee CM, Zhuo X, White S, Shaw J, Morton RL, Colagiuri S, Chadban SJ.

Intern Med J. 2015 May 6. doi: 10.1111/imj.12797. [Epub ahead of print]

PMID:
25944415
3.

Research Priorities in CKD: Report of a National Workshop Conducted in Australia.

Tong A, Crowe S, Chando S, Cass A, Chadban SJ, Chapman JR, Gallagher M, Hawley CM, Hill S, Howard K, Johnson DW, Kerr PG, McKenzie A, Parker D, Perkovic V, Polkinghorne KR, Pollock C, Strippoli GF, Tugwell P, Walker RG, Webster AC, Wong G, Craig JC.

Am J Kidney Dis. 2015 May 2. pii: S0272-6386(15)00593-4. doi: 10.1053/j.ajkd.2015.02.341. [Epub ahead of print]

PMID:
25943716
4.

HbA1c Is Insensitive at Month 3 After Kidney Transplantation.

Clayton PA, Aouad L, Wyburn KR, Eris JM, Chadban SJ.

Transplantation. 2015 May;99(5):e37-8. doi: 10.1097/TP.0000000000000683. No abstract available.

PMID:
25943236
5.

IL-17 Deficiency Attenuates Allograft Injury and Prolongs Survival in a Murine Model of Fully MHC-Mismatched Renal Allograft Transplantation.

Kwan T, Chadban SJ, Ma J, Bao S, Alexander SI, Wu H.

Am J Transplant. 2015 Jun;15(6):1555-67. doi: 10.1111/ajt.13140. Epub 2015 Mar 30.

PMID:
25824574
6.

Dangers of broth after transplantation.

Aggarwal S, Sukkar L, Wynter L, Richards K, Cheung J, Chadban SJ.

Nephrology (Carlton). 2015 Apr;20(4):297-9. doi: 10.1111/nep.12391.

PMID:
25810227
7.

Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.

Lim WH, Gray NA, Chadban SJ, Pilmore H, Wong G.

Transpl Int. 2015 May;28(5):610-8. doi: 10.1111/tri.12542. Epub 2015 Mar 3.

PMID:
25689280
8.

Pregnancy outcomes for kidney transplant recipients with transplantation as a child.

Wyld ML, Clayton PA, Kennedy SE, Alexander SI, Chadban SJ.

JAMA Pediatr. 2015 Feb;169(2):e143626. doi: 10.1001/jamapediatrics.2014.3626. Epub 2015 Feb 2.

PMID:
25642905
9.

The expectations and attitudes of patients with chronic kidney disease toward living kidney donor transplantation: a thematic synthesis of qualitative studies.

Hanson CS, Chadban SJ, Chapman JR, Craig JC, Wong G, Ralph AF, Tong A.

Transplantation. 2015 Mar;99(3):540-54. doi: 10.1097/TP.0000000000000433.

PMID:
25463967
10.

Is it time to increase access to transplantation for those with diabetic end-stage kidney disease?

Chadban SJ, Staplin ND.

Kidney Int. 2014 Sep;86(3):464-6. doi: 10.1038/ki.2014.154.

PMID:
25168496
11.

Macrophages in renal transplantation: Roles and therapeutic implications.

Kwan T, Wu H, Chadban SJ.

Cell Immunol. 2014 Sep-Oct;291(1-2):58-64. doi: 10.1016/j.cellimm.2014.05.009. Epub 2014 Jun 14. Review.

PMID:
24973994
12.

External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States.

Clayton PA, McDonald SP, Snyder JJ, Salkowski N, Chadban SJ.

Am J Transplant. 2014 Aug;14(8):1922-6. doi: 10.1111/ajt.12761. Epub 2014 Jun 5.

PMID:
24903739
13.

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium.

JAMA. 2014 Jun 25;311(24):2518-31.

PMID:
24892770
14.

TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.

Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, Pollock CA, Wu H.

PLoS One. 2014 May 19;9(5):e97985. doi: 10.1371/journal.pone.0097985. eCollection 2014.

15.

Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Ma J, Wu H, Zhao CY, Panchapakesan U, Pollock C, Chadban SJ.

Int J Clin Exp Pathol. 2014 Jan 15;7(2):481-95. eCollection 2014.

16.

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, Kühn J, Hafezi W, Campbell IL, Reilly D, Say J, Brown L, White MY, Cordwell SJ, Chadban SJ, Thorp EB, Bao S, Miller SD, King NJ.

Sci Transl Med. 2014 Jan 15;6(219):219ra7. doi: 10.1126/scitranslmed.3007563.

17.

Knowledge deficit of patients with stage 1-4 CKD: a focus group study.

Lopez-Vargas PA, Tong A, Phoon RK, Chadban SJ, Shen Y, Craig JC.

Nephrology (Carlton). 2014 Apr;19(4):234-43. doi: 10.1111/nep.12206.

PMID:
24428274
18.

Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice.

Wu H, Steenstra R, de Boer EC, Zhao CY, Ma J, van der Stelt JM, Chadban SJ.

Kidney Int. 2014 Apr;85(4):824-32. doi: 10.1038/ki.2013.475. Epub 2013 Dec 18.

PMID:
24352152
19.

Roles of Toll-like receptors in transplantation.

Wu H, Chadban SJ.

Curr Opin Organ Transplant. 2014 Feb;19(1):1-7. doi: 10.1097/MOT.0000000000000038. Review.

PMID:
24316761
20.

A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.

Chadban SJ, Eris JM, Kanellis J, Pilmore H, Lee PC, Lim SK, Woodcock C, Kurstjens N, Russ G; SOCRATES Study Group.

Transpl Int. 2014 Mar;27(3):302-11. doi: 10.1111/tri.12252. Epub 2014 Jan 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk